David A. Catanzaro
Research Subjects
David A. Catanzaro has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Angela J. Bs Westover
Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI
1 shared publication Christopher J. Pino
Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor, MI
1 shared publication- David A Catanzaro
SeaStar Medical
1 shared publication Emily C Scribe
1 shared publicationH David Humes
University of Michigan, Weil Institute for Critical Care Research & Innovation
1 shared publication- Harvey David Humes
University of Michigan
1 shared publication
Latest Publications
- Open Access
- 16 May 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (6) , e1627
Increasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions
A stable, minimum physiological health status is required for patients to qualify for transplant or artificial organ support eligibility to ensure the recipient has enough reserve to survive the perioperative transplant period. Herein, we present a novel strategy to stabilize and improve patient clinical status through extracorporeal immunomodulation of systemic hyperinflammation with impact on multiple organ systems to increase eligibility and feasibility for transplant/device implantation. This involves treatment with the selective cytopheretic device (SCD), a cell-directed extracorporeal therapy shown to adhere and immunomodulate activated neutrophils and monocytes toward resolution of systemic inflammation. In this overview, we describe a case series of successful transition of pediatric and adult patients with multiorgan failure to successful transplant/device implantation procedures by treatment with the SCD in the following clinical situations: pediatric hemophagocytic lymphohistiocytosis, and adult hepatorenal and cardiorenal syndromes. Application of the SCD in these cases may represent a novel paradigm in increasing clinical eligibility of patients to successful transplant outcomes. Export
- 16 May 2024
- Published by Wolters Kluwer Health in Transplantation Direct
- Vol. 10 (6) , e1627
Open AccessIncreasing Eligibility to Transplant Through the Selective Cytopheretic Device: A Review of Case Reports Across Multiple Clinical Conditions
A stable, minimum physiological health status is required for patients to qualify for transplant or artificial organ support eligibility to ensure the recipient has enough reserve to survive the perioperative transplant period. Herein, we present a novel strategy to stabilize and improve patient clinical status through extracorporeal immunomodulation of systemic hyperinflammation with impact on multiple organ systems to increase eligibility and feasibility for transplant/device implantation. This involves treatment with the selective cytopheretic device (SCD), a cell-directed extracorporeal therapy shown to adhere and immunomodulate activated neutrophils and monocytes toward resolution of systemic inflammation. In this overview, we describe a case series of successful transition of pediatric and adult patients with multiorgan failure to successful transplant/device implantation procedures by treatment with the SCD in the following clinical situations: pediatric hemophagocytic lymphohistiocytosis, and adult hepatorenal and cardiorenal syndromes. Application of the SCD in these cases may represent a novel paradigm in increasing clinical eligibility of patients to successful transplant outcomes. Export
- Open Access
- 27 July 2023
- Published by Wiley
Safety Summary of the Selective Cytopheretic Device (SCD): A Review of Safety Data Across Multiple Clinical Trials in ICU Patients with Acute Kidney Injury and Multi-Organ Failure
A document by David Catanzaro. Click on the document to view its contents.
- 27 July 2023
- Published by Wiley
Open AccessSafety Summary of the Selective Cytopheretic Device (SCD): A Review of Safety Data Across Multiple Clinical Trials in ICU Patients with Acute Kidney Injury and Multi-Organ Failure
A document by David Catanzaro. Click on the document to view its contents.